Head-To-Head Contrast: Chemours (NYSE:CC) and Kiwa Bio-Tech Products Group (OTCMKTS:KWBT)

Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) and Chemours (NYSE:CC) are both basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Kiwa Bio-Tech Products Group and Chemours, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kiwa Bio-Tech Products Group	0	0	0	0	0.00
Chemours	2	3	5	0	2.30

Chemours has a consensus target price of $17.50, indicating a potential upside of 36.83%. Given Chemours’ stronger consensus rating and higher possible upside, analysts clearly believe Chemours is more favorable than Kiwa Bio-Tech Products Group.

Profitability

This table compares Kiwa Bio-Tech Products Group and Chemours’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kiwa Bio-Tech Products Group	N/A	N/A	N/A
Chemours	-5.70%	35.27%	2.03%

Valuation & Earnings

This table compares Kiwa Bio-Tech Products Group and Chemours”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kiwa Bio-Tech Products Group	N/A	N/A	N/A	N/A	N/A
Chemours	$5.78 billion	0.33	$86.00 million	($2.22)	-5.76

Chemours has higher revenue and earnings than Kiwa Bio-Tech Products Group.

Institutional and Insider Ownership

76.3% of Chemours shares are held by institutional investors. 1.3% of Kiwa Bio-Tech Products Group shares are held by insiders. Comparatively, 0.3% of Chemours shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Chemours beats Kiwa Bio-Tech Products Group on 7 of the 9 factors compared between the two stocks.

About Kiwa Bio-Tech Products Group

Kiwa Bio-Tech Products Group Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers. The company has a strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center; China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning; and Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.